Matthew Johnson, MD
Otolaryngology · Kearney, NENPI 1750677894
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Sanofi at 27.2% of the total.
Across 63 payments — averaging $26.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$452
- Stryker$238
- Regeneron Healthcare Solutions, Inc.$203
- Aerin Medical Inc.$161
- Optinose US, Inc.$136
- Medtronic$123
- plus $350 from 10 others
What the payments were for
- Food & beverage$1,663100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 17 | $452 |
| Stryker | 8 | $238 |
| Regeneron Healthcare Solutions, Inc. | 6 | $203 |
| Aerin Medical Inc. | 5 | $161 |
| Optinose US, Inc. | 9 | $136 |
| Medtronic | 1 | $123 |
| Inspire Medical Systems, Inc. | 3 | $110 |
| Acclarent, Inc | 4 | $81 |
| Bayer | 2 | $28 |
| GSK | 2 | $27 |
| Smith+Nephew | 1 | $22 |
| Cochlear Americas | 1 | $21 |
| Alk-abello, Inc | 1 | $19 |
| Merck | 1 | $14 |
| Zimmer Biomet | 1 | $14 |
| Intersect ENT, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CoreValve Evolut$123
- DUPIXENT$100
How this compares
$1,663 in reported general payments places this provider in the 65th percentile of 86 otolaryngology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ofloxacin | 18 | $1,022 |
| Pantoprazole Sodium | 40 | $722 |
| Ipratropium Bromide | 19 | $642 |
| Omeprazole | 60 | $520 |
| Triamcinolone Acetonide | 16 | $431 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 21 | $394 |
| Fluticasone Propionate | 31 | $367 |
| Levothyroxine Sodium | 35 | $341 |
| Azelastine Hcl | 12 | $220 |
| Levocetirizine Dihydrochloride | 20 | $193 |
| Lidocaine Hcl ViscousLidocaine Hcl | 13 | $193 |
| Mupirocin | 26 | $186 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $147 |
| Clindamycin Hcl | 11 | $134 |
| Methylprednisolone | 11 | $117 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Kearney
- Michael KlinginsmithKearney$2K
- Thomas ConnelyKearney$2K
- Aaron RobinsonLincoln$51K
- Demetrio AguilaPapillion$50K
- Rahul VarmanOmaha$13K
- Daniel O'BrienOmaha$10K
- Wallace DuffOmaha$8K
- Jenna BergLincoln$4K
- Tyler BlissOmaha$4K
- Adam PleasOmaha$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.